Reapplix A/S
CVR 31261570 · Public limited company (A/S) · Active · Low risk
Reapplix A/S is a Public limited company (A/S), founded on , based in Birkerød. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 17 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 12.0m and a net result of DKK -37.6m. CEO: Morten Have-Rasmussen.
Bankruptcy risk for Reapplix A/S
0.4 × the average (1.41%) · higher risk than 59% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 31261570
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (18 years)
- Address
- Bregnerødvej 133, st.
3460 Birkerød - Municipality
- Rudersdal
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 9.2m
- Employees
- 8 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 4 of 17 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 79.4% |
| Current ratio | 377% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 4 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 43 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | DKK 1.6m | DKK 885k | DKK 1.8m |
| Gross profit | DKK -2.7m | DKK -2.5m | DKK -2.1m |
| Net profit | DKK -37.6m | DKK -45.1m | DKK -43.1m |
| Equity | DKK 12.0m | DKK 12.3m | DKK 57.5m |
| Total assets | DKK 15.2m | DKK 16.4m | DKK 62.0m |
| Cash | DKK 6.2m | DKK 9.0m | – |
| Short-term debt | DKK 2.8m | DKK 3.9m | – |
| Tax owed | DKK 0 | DKK 0 | – |
| Avg. employees | 7 | 7 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · (venstre underskriver).
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 183 | ||
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 1 Jan 2023 – 31 Dec 2023 | 184 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 180 | ||
| 1 Jan 2021 – 31 Dec 2021 | 182 | ||
| 1 Jan 2020 – 31 Dec 2020 | 188 | Late | |
| 1 Jan 2019 – 31 Dec 2019 | 223 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 155 | ||
| 1 Jan 2017 – 31 Dec 2017 | 159 | ||
| 1 Jan 2016 – 31 Dec 2016 | 148 | ||
| 1 Jan 2015 – 31 Dec 2015 | 84 | ||
| 1 Jan 2014 – 31 Dec 2014 | 113 | ||
| 1 May 2012 – 30 Apr 2013 | 152 | ||
| 1 May 2011 – 30 Apr 2012 | 118 | ||
| 1 May 2010 – 30 Apr 2011 | 158 | ||
| 1 May 2009 – 30 Apr 2010 | 146 | ||
| 4 Feb 2008 – 30 Apr 2009 | 96 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Morten Have-Rasmussen | Current | |
| CEO | Rasmus Lundquist | ||
| CEO | Niels Erik Holm | ||
| Board | Tonni Bülow-Nielsen | Current | |
| Board | Søren Møller | Current | |
| Board | Bo Jesper Hansen | Current | |
| Board | Samuel Levy | Current | |
| Board | Kira Paniagua Rupprecht | Current | |
| Board | Klaus Eldrup-Jørgensen | Current | |
| Board | Jørgen Ulrik Vejlsgaard | Current | |
| Board | Rasmus Lundquist | ||
| Board | Bo Jesper Hansen | ||
| Board | Line Holten Reimer | ||
| Board | Carsten Schou | ||
| Board | Peter Gerhard Friedrich Hentschel | ||
| Board | Ulf Lennart Rosén | ||
| Board | Ulrik Spork | ||
| Board | Birgit Aagaard-Svendsen | ||
| Board | Cyrille Yann Nicolas Petit | ||
| Board | Ulrik Spork | ||
| Board | Klaus Eldrup-Jørgensen | ||
| Board | Jørgen Ulrik Vejlsgaard | ||
| Board | Richard Twomey | ||
| Board | Ulrik Spork | ||
| Board | Richard Twomey | ||
| Board | Jørgen Ulrik Vejlsgaard | ||
| Board | Richard Twomey | ||
| Owner (5%) | Bo Jesper Hansen | Current | |
| Owner (5%) | Jan Struve | Current | |
| Owner (15%) | Novo Holdings A/S | Current | |
| Owner (15%) | Danmarks Eksport- og Investeringsfond | Current | |
| Owner (10%) | North-East Health Care Holding ApS | Current | |
| Owner (10%) | MK VENTURES ApS | Current | |
| Owner (5%) | SEED CAPITAL DENMARK II K/S | Current | |
| Owner (10%) | Lauxera Growth I S.L.P | Current | |
| Owner (5%) | PreSeed Ventures A/S | ||
| Owner (15%) | VÆKSTFONDEN | ||
| Owner (5%) | Lundquist Medical ApS | ||
| Owner (10%) | N. E. HOLM A/S | ||
| Owner (15%) | Novo Holdings A/S | ||
| Owner (33%) | SEED CAPITAL DENMARK II K/S | ||
| Owner (20%) | VÆKSTFONDEN | ||
| Owner (5%) | N. E. HOLM A/S | ||
| Owner (20%) | Novo Holdings A/S | ||
| Owner (33%) | SEED CAPITAL DENMARK II K/S | ||
| Owner (25%) | SEED CAPITAL DENMARK II K/S | ||
| Owner (5%) | Bo Jesper Hansen | ||
| Owner (5%) | Jan Struve | ||
| Owner (15%) | VÆKSTFONDEN | ||
| Owner (15%) | Novo Holdings A/S | ||
| Owner (20%) | SEED CAPITAL DENMARK II K/S | ||
| Owner (5%) | MK VENTURES ApS | ||
| Owner (15%) | SEED CAPITAL DENMARK II K/S | ||
| Owner (5%) | North-East Health Care Investment ApS | ||
| Owner (5%) | Lauxera Growth Opportunity 1 | ||
| Owner (5%) | Lauxera Growth I S.L.P | ||
| Owner (15%) | Danmarks Eksport- og Investeringsfond | ||
| Owner (5%) | MK VENTURES ApS | ||
| Owner (10%) | SEED CAPITAL DENMARK II K/S | ||
| Owner (5%) | North-East Health Care Investment ApS | ||
| Owner (5%) | Lauxera Growth I S.L.P | ||
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab | ||
| Founder | Lundquist Medical ApS | Current | |
| Founder | N. E. HOLM A/S | Current |
The CEOs' other companies
Rasmus Lundquist – 3 other companies
- Lundquist Medical ApS Active
- RAM BIOTECH ApS Active
- Rheia Medical ApS Active
Niels Erik Holm – 9 other companies
- CUBITECH A/S Opløst
- INNOVENTA MEDICA ApS Active
- N. E. HOLM A/S Active
- NETDEVELOPERS ApS Opløst
- Roto Health ApS Active
- THREE STONES COMPANY A/S Compulsorily dissolved
- TeXpansion Technology ApS Opløst
- UNES ApS Opløst
- VIVOSTAT A/S Active
Address history (2 moves)
| Bregnerødvej 133, st., 3460 Birkerød | |
| Blokken 45, 3460 Birkerød | |
| Julmosevej 10 b, 3460 Birkerød |
Former names
| Reapplix A/S | – now |
| REAPPLIX ApS | – |
Employees per year
Other companies at the same address
- B&J EJENDOMSINVEST ApS Bankrupt
- HANDSTEP A/S Bankrupt
- HERMES PROJEKTUDVIKLING A/S Bankrupt
- POUL HENNINGSEN PIANOFABRIK A/S Bankrupt
- W3 INVESTMENT ApS Bankrupt
- 3:BO A/S Fusioneret
- ACUBIZ DANMARK ApS Opløst
- ACUBIZ EMS ApS Fusioneret
- ACUBIZ HOLDING ApS Fusioneret
- ADDICI FACILITY MANAGEMENT A/S Fusioneret
- Acubiz IPR ApS Fusioneret
- Avantis Distribution ApS Opløst
- BROCK & MICHELSEN INVEST A/S Fusioneret
- C Consumer Products Denmark ApS Opløst
- CARL ZEISS A/S Active
- CARL ZEISS VISION DANMARK A/S Active
- COMPEED HOLDING ApS Fusioneret
- COOR SERVICE MANAGEMENT GS ApS Opløst
- DAMGAARD A/S Fusioneret
- DELFIN HOLDING II ApS Opløst
- DELFIN INVESTERINGSSELSKAB ApS Opløst
- DS - DISPLAY A/S Fusioneret
- Datoselskabet af December 2018 ApS Opløst
- EET A/S Fusioneret
- EET A/S Active
Similar companies in Rudersdal
- Threepoint Therapeutics ApS Hørsholm
- Zaphe ApS Hørsholm
- Floratinia ApS Holte
- Dirac Drives ApS Hørsholm
- Johnsen Bioconsult ApS Skodsborg
- Dantefusion ApS Birkerød
- Typo foods ApS Vedbæk
- Pexinno ApS Holte
- Cerdes Science ApS Birkerød
- Pedersen Scientific ApS Birkerød
- NaviSurg Vision ApS Holte
- Fluispotter ApS Vedbæk
Questions and answers about Reapplix A/S
Has Reapplix A/S gone bankrupt?
No, Reapplix A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Reapplix A/S?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of Reapplix A/S?
Morten Have-Rasmussen is the CEO of Reapplix A/S.
Who is the auditor of Reapplix A/S?
Reapplix A/S most recently used EY Godkendt Revisionspartnerselskab.
When was Reapplix A/S founded?
Reapplix A/S was founded on 4 February 2008.
What is the equity of Reapplix A/S?
Equity was DKK 12.0m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.